1-4 of 4
leukemia, t-cell, chronic
Close
Sort by
Journal Articles

Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia

Victoria M. Smith, Oliver Lomas, Donna Constantine, Lianne Palmer, Anna H. Schuh, David Bruce, Oksana Gonchar, Salvador Macip, Sandrine Jayne, Martin J. S. Dyer, Toby A. Eyre
Journal: Blood Advances
Blood Adv (2020) 4 (3): 525–529.
https://doi.org/10.1182/bloodadvances.2019000917
Published: 2020
Includes: Supplemental data
Journal Articles

Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia

Clinical Trials & Observations
Fares Alsawah, Lydia Benitez, Sarah Choi, Bernard Marini, Anthony Perissinotti, Amy Skyles, Patrick Burke, Kristen Pettit, Ashley Crouch, Heather Fox, Dale Bixby
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3333–3336.
https://doi.org/10.1182/bloodadvances.2019000289
Published: 2019
Journal Articles

T-cell prolymphocytic leukemia in an adolescent with ataxia-telangiectasia: novel approach with a JAK3 inhibitor (tofacitinib)

Clinical Trials & Observations
Geling Li, Emily Waite, Julie Wolfson
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2724–2728.
https://doi.org/10.1182/bloodadvances.2017010470
Published: 2017
Journal Articles

Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia

Elizabeth A. Morgan, Mark N. Lee, Daniel J. DeAngelo, David P. Steensma, Richard M. Stone, Frank C. Kuo, Jon C. Aster, Christopher J. Gibson, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1786–1789.
https://doi.org/10.1182/bloodadvances.2017011197
Published: 2017
Includes: Supplemental data